Chargement en cours...
Virologic response and haematologic toxicity of boceprevir- and telaprevir-containing regimens in actual clinical settings
Effectiveness, safety and tolerability of boceprevir (BOC) and telaprevir (TPV) in actual clinical settings remain unknown. We determined rates of sustained virologic response (SVR) and haematologic adverse effects among persons treated with BOC- or TPV-containing regimens, compared with pegylated i...
Enregistré dans:
| Publié dans: | J Viral Hepat |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5020421/ https://ncbi.nlm.nih.gov/pubmed/25524834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvh.12375 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|